Media headlines about Neovasc Inc (US) (NASDAQ:NVCN) (TSE:NVC) have trended somewhat positive recently, Accern reports. The research group identifies negative and positive media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Neovasc Inc (US) earned a news impact score of 0.19 on Accern’s scale. Accern also gave news stories about the medical equipment provider an impact score of 45.7940342689721 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
These are some of the news stories that may have impacted Accern Sentiment Analysis’s scoring:
- Analysts Perspectives: Neovasc Inc (NVCN) – Emn News (emnnews.com)
- Neovasc Inc. (NVCN) Smart Insider Ownership of 32.55% – Wallstreet Investorplace (wallstreetinvestorplace.com)
- Neovasc Inc (NVCN) Ended after Adding 10.19% – ExpertGazette (expertgazette.com)
- Technical Indicators in Focus – Neovasc Inc. (NASDAQ: NVCN) – Alpha Beta Stock (alphabetastock.com)
- Neovasc Inc. (NASDAQ:NVCN) – Hair-Raising Facts to Know – Nasdaq Journal (press release) (nasdaqjournal.com)
Several brokerages have recently weighed in on NVCN. ValuEngine lowered Neovasc Inc (US) from a “sell” rating to a “strong sell” rating in a report on Sunday, December 31st. Zacks Investment Research lowered Neovasc Inc (US) from a “buy” rating to a “hold” rating in a research note on Wednesday, October 18th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $3.58.
Shares of Neovasc Inc (NASDAQ:NVCN) opened at $0.53 on Friday. Neovasc Inc has a one year low of $0.50 and a one year high of $2.12. The company has a market capitalization of $45.31, a price-to-earnings ratio of 2.22 and a beta of -0.08.
About Neovasc Inc (US)
Neovasc Inc (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company’s segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products.
Receive News & Ratings for Neovasc Inc (US) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc Inc (US) and related companies with MarketBeat.com's FREE daily email newsletter.